151 completed, 49 unknown, 22 terminated, 18 not yet recruiting. 87 Phase 3, 74 Phase 4, 46 Not applicable, 42 Phase 2, 20 Phase 1.
Follow Levofloxacin: new trials by email Literature Review of Levofloxacin trials Research Report on Levofloxacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vonoprazan High-Dose Dual VS Levofloxacin Concomitant Vonoprazan, Levofloxacin 500mg - Helicobacter Pylori Infection, Peptic Ulcer Disease | Phase 4 | Not yet recruiting | Damascus Hospital | 150 | 2026-11-01 | 2026-06-03 |
| All-Oral Fluoroquinolone-Based Triple Therapies for Adults With Imaging-Confirmed Osteoarticular Brucellosis Doxycycline + Rifampicin + Ceftriaxone (intravenous therapy for 4 weeks), Triple oral regimen (Doxycycline + Rifampicin + Levofloxacin), Triple oral regimen (Doxycycline + Rifampicin + Moxifloxacin) - Brucellosis, Osteoarticular Brucellosis | Not applicable | Not yet recruiting | The First Affiliated Hospital of Shihezi University | 150 | 2026-11-01 | 2026-10-21 |
| Fluoroquinolone-Doxycycline Oral Treatments for Adults With Uncomplicated Brucellosis Doxycycline + Rifampicin, Doxycycline + Levofloxacin, Doxycycline + Moxifloxacin - Brucellosis | Not applicable | Not yet recruiting | The First Affiliated Hospital of Shihezi University | 200 | 2026-11-01 | 2026-10-21 |
| A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis MDR-END Plus regimen, Standard-of-care (SoC) treatment - Rifampicin-Resistant Tuberculosis | Phase 3 | Not yet recruiting | Seoul National University Hospital | 294 | 2026-10-01 | 2026-06-30 |
| Efficacy & Safety of Fluoroquinolone-Based Brucellosis Regimens (BRUCE) Doxycycline + Rifampicin, Doxycycline + Levofloxacin, Doxycycline + Moxifloxacin - Brucellosis, Osteoarthritis | Not applicable | Withdrawn | The First Affiliated Hospital of Shihezi University | 2026-10-01 | 2026-10-27 | |
| Intracameral Levofloxacin Versus Moxifloxacin After Cataract Surgery Levofloxacin, Moxifloxacin - Cataract, Postoperative Endophthalmitis | Not applicable | Not yet recruiting | Assiut University | 93 | 2026-09-26 | 2026-09-30 |
| Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) Levofloxacin, Usual Care - Myeldysplastic Syndrome (MDS), MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) | Phase 2 | Not yet recruiting | University of Manitoba | 75 | 2026-09-01 | 2026-06-29 |
| Efficacy and Safety of Piclosept in the Complex Treatment of Neonatal Dacryocystitis Picloxidine, Levofloxacin, Standardized lacrimal sac massage - Neonatal Dacryocystitis, Congenital Nasolacrimal Duct Obstruction | Phase 4 | Active not recruiting | Kazakh Eye Research Institute | 90 | 2026-08-25 | 2026-10-15 |
| Rationale of Subcutaneous Levofloxacin Infiltration as an Adjunct for Surgical Site Infection Prevention in Emergency Laparotomy Levofloxacin - Surgical Site Infection (SSI) | Not applicable | Not yet recruiting | Sylhet M.A.G.Osmani Medical College | 90 | 2026-08-01 | 2026-07-13 |
| Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women Standard dose rifampicin, High dose rifampicin, Standard dose isoniazid - Tuberculosis Infection, Healthy Volunteer | Phase 1 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 60 | 2026-06-01 | 2026-11-02 |
| Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB Bedaquiline, Isoniazid, rifapentine, Levofloxacin - Tuberculosis, Latent | Phase 2 / Phase 3 | Recruiting | Johns Hopkins University | 2530 | 2026-05-08 | 2026-10-20 |
| Enhanced Treatment Strategy for Disseminated MAC Infection in HIV Patients: A Randomized Controlled Trial Standard Triple Therapy, Experimental: Standard Triple Therapy Plus Fluoroquinolone - Opportunistic Infections, HIV Related, Disseminated Mycobacterium Avium Complex Infection | Not applicable | Not yet recruiting | Shanghai Public Health Clinical Center | 124 | 2026-04-30 | 2026-05-13 |
| Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase Levofloxacin, Placebo - Neutropenic Fever, Acute Lymphoblastic Leukemia | Phase 4 | Terminated | Gadjah Mada University | 49 | 2026-01-01 | 2026-10-01 |
| Comparison of Two Treatment Regimens of Helicobacter Pylori Infection Clarithromycin, Levofloxacin - Helicobacter Pylori Infection | Phase 4 | Not yet recruiting | Rehman Medical Institute - RMI | 156 | 2025-12-01 | 2025-06-15 |
| 6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province bedaquiline, Delamanid (DLM), Linezolid (LZD) - Treat to Target, Treatment Duration | Not applicable | Not yet recruiting | Wuhan Pulmonary Hospital | 52 | 2025-09-30 | 2025-09-30 |
| A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis bedaquiline, Pretomanid (Pa), linezolid - Efficacy and Safety | Not applicable | Not yet recruiting | Wuhan Pulmonary Hospital | 200 | 2025-09-01 | 2025-08-17 |
| Tailored Vs. Empirical Helicobacter Pylori Infection Treatment Clarithromycin (mutations in the 23S rRNA gene, A2134G, A2142G and A2142C mutations) and levofloxacin resistance (mutations in the gyrA gene) PCR test, Empirically H. pylori eradication treatment with bismuth quadruple therapy (Pylera®), PPI, amoxicillin 1 g and clarithromycin 500 mg, twice daily, for 10 days - Helicobacter Pylori Infection | Phase 4 | Not yet recruiting | Manuel Coelho da Rocha | 160 | 2025-09-01 | 2024-12-20 |
| Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection Clarithromycin 500 mg, Amoxicillin 1 g, Omeprazole 40 mg - H Pylori | Phase 4 | Not yet recruiting | Rehman Medical Institute - RMI | 128 | 2025-07-01 | 2025-06-27 |
| Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea Piperacillin/Tazobactam, Piperacillin/tazobactam + Levofloxacin - Severe Community-acquired Pneumonia (sCAP) | Not applicable | Not yet recruiting | CHOSEOK YOON | 100 | 2025-06-15 | 2025-05-18 |
| Shorter and Safer Treatment Regimens for Latent TB rifampin standard arm, rifampin double dose, levofloxacin and rifapentine - Tuberculosis Infection, Latent | Phase 2 / Phase 3 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 1800 | 2025-06-10 | 2026-05-11 |
Showing 20 of 265. Sign in to see all of them.
Community-Acquired Pneumonia (16) · Urinary Tract Infections (14) · Pneumonia (12) · Infections (11) · Tuberculosis, Multidrug-Resistant (11) · Tuberculosis (10) · Tuberculosis, Pulmonary (9) · Bacterial Infections (7) · Cataract (6) · Lung Diseases (6) · Prostatitis (6) · Appendicitis (5) · Bronchitis, Chronic (5) · Pneumonia, Bacterial (5) · Pyelonephritis (5)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (24) · Shandong University (7) · Damascus Hospital (6) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · Seoul National University Hospital (5) · Shanghai Jiao Tong University School of Medicine (5) · Bayer (4) · Pfizer (4) · Sanofi (4) · Ain Shams University (3) · Beijing Chest Hospital (3) · Boston University (3) · Kaohsiung Veterans General Hospital. (3) · NTC srl (3) · National Taiwan University Hospital (3)
United States (56) · China (44) · Italy (15) · France (13) · Spain (13) · Canada (12) · Taiwan (12) · Egypt (11) · Germany (11) · Russia (11) · South Africa (11) · South Korea (11) · India (9) · Pakistan (9) · Greece (7)
Xiuli Zuo, MD,PhD (4) · Marouf M Alhalabi, MD (3) · Ping-I Hsu, Bachelor (3) · David Prior (2) · Dick Menzies, MD (2) · Francesco Bandello, Prof. (2) · George G Zhanel, PhD, FCCP (2) · Hong Lu, M.D. (2) · Li Yanqing, MD, PhD (2) · Lindsay E Nicolle, MD, FRCPC (2)
PMID 39382091, PMID 12039901, PMID 12145720, PMID 12749509, PMID 12946763, PMID 12955634, PMID 14986270, PMID 15276398, PMID 15329363, PMID 15530127, PMID 15557948, PMID 1559306, PMID 15840453, PMID 16148284, PMID 16236878, PMID 16420547, PMID 16631047, PMID 16776446, PMID 16965625, PMID 16982292, PMID 17133154, PMID 17178300, PMID 17261234, PMID 17313438, PMID 17509029, PMID 17531690, PMID 17696583, PMID 17854602, PMID 17880755, PMID 17901791, PMID 18042477, PMID 18061594, PMID 18070980, PMID 18211932, PMID 18242357, PMID 18419482, PMID 18446147, PMID 18462108, PMID 18508226, PMID 18702902, PMID 18787216, PMID 18818959, PMID 19036672, PMID 19128645, PMID 19238021, PMID 19286178, PMID 19419343, PMID 19564361, PMID 19588358, PMID 19740418
2015 (2), 2008 (1), 2014 (1), 2017 (1), 2023 (1), R01HD074944 (1), R01HL117074 (1), U01AI100805 (1), U01AI152980 (1), U10CA095861 (1)